Ancor Capital Partners is pleased to announce the acquisition of WellSpring Pharmaceutical Corporation based in Sarasota, Florida and Toronto, Ontario. WellSpring is a manufacturer and marketer of specialty prescription and over-the-counter (OTC) products in North America. The company also offers contract manufacturing through its production plant, located in Ontario, Canada. “WellSpring represents the fifteenth acquisition...Read More